OAKLAND, Calif., July 26, 2019 /PRNewswire-PRWeb/ -- With the CBD industry projected to hit $20 billion by 2024, countless entrepreneurs aim to reap the benefits of hemp's return to American agriculture.
However, one particular company is taking a new approach with some old faces. Spero CBD was co-founded by 15-year industry veteran Justin Jarin, owner of the country's 2nd oldest dispensary and who sold more than $25 million worth of cannabis products in 2017 alone.
After being asked why he thought this company was on the fasttrack to success, Justin said "The single question I get asked about most when people learn what industry I am in is about CBD. People are very excited about it, and for good reason, but I know from experience how difficult it is to source a consistent high quality CBD product. Spero aims to solve this problem".
Spero's products are produced using the cutting-edge filtration process known as liquid chromatography to completely remove even the smallest trace amounts of THC.
THC is the compound that leads to the euphoric feeling or "high". By filtering it out, Spero has ensured that their products are completely non-psychoactive.
Other CBD companies aiming for a THC free product typically use boiling methods to distill the raw extraction into what is known as CBD isolate. However this process degrades the raw extract and produces unwanted isomers and degradation compounds which are not naturally occurring and their effects on humans are unknown.
Liquid chromatography ensures traces of THC or other synthetic compounds don't make their way into the final product which means it won't show up on a drug test.
Every product Spero releases is first tested by third-party laboratories to ensure a due level of unbiased quality control is maintained.
Beyond the innovate refinement process, Spero boasts that no pesticides are present in their product.
Spero's products are classified as full-spectrum because they're a whole-plant extract rather than a CBD isolate. This means that there are other beneficial minor cannabinoids present allowing them to work synergistically together with CBD in what has been coined as the "Entourage Effect" by scientists. Studies have shown that full-spectrum products are more -- effective due to the fact that they contain all the beneficial cannabinoids from the cannabis sativa plant. Other products may claim to be "whole plant" but due to a less sophisticated refinement process they are not full spectrum.
The revolutionary company has also been hard at work coming up with a diverse selection of CBD products to fulfill consumer needs and relieve pain points.
A common complaint amongst CBD users is that the taste or odor of oil tinctures are unappetizing. Spero's answer to this is a peppermint-flavored tincture. Unflavored tinctures are also available for those who prefer the pure taste of CBD oil.
The company has also introduced gel capsules as an alternative. They come in doses of 25mg and some are even combined with other compounds such as turmeric or melatonin. The latter could be useful for those who have issues with insomnia.
CBD has also seen rapid growth in the 11-figure pet care market, which is why it should come as no surprise that Spero offers various treats and tinctures for pets as well.
When asked about the implications of CBD for animal welfare, Spero co-founder and former 11-year Senior Director for The Humane Society of the United States Christine Gutleben stated "Veterinary providers, pet owners and shelters are paying increased attention to problems like anxiety in pets. CBD is a healthy, natural calming aid in addition to providing a myriad of health benefits. Studies show that animals have an endocanibinoid system and benefit from CBD in similar ways to people.."
The company is currently evaluating flavorless CBD water for pets to add to their pet product line.. Other items in the works at the Spero lab include skin products and vape cartridges.
When not coming up with new products to take to market, Spero is devising altruistic strategies of giving back to the community.
The current roadmap highlights a donation of 3% of gross sales in the form of CBD products to children who suffer from epilelpsy, Alzheimer's patients, recovering opiate addicts, and animals in shelters.
It's clear that the founding members of Spero are in it for the long haul and have big plans for the company. Spero's CEO David Allred was asked about the primary focus of the company for the next two quarters, to which he responded "It's all about gaining space in the market and we feel confident we can build a community around giving back, education and what separates a high quality product from inferior ones. There is a noticeable difference between the two and were looking forward to allowing customers to see this for themselves".
SOURCE Spero
Share this article